Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06812832 · ClinicalTrials.gov registry record · Phase 4
Simethicone as Part of ERAS in Bariatric Surgery Patients
A Phase 4 study of Postoperative Pain and Bariatric Surgery, sponsored by Madigan Army Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 260
- Enrollment target
- 1
- Study location
NCT06812832: Recruiting Phase 4 study of Postoperative Pain and Bariatric Surgery, sponsored by Madigan Army Medical Center.
NCT06812832 is a Phase 4 study of Postoperative Pain and Bariatric Surgery that is actively recruiting participants, run by Madigan Army Medical Center. The registered enrollment target is 260 participants, above the 230-participant average among 120 other Postoperative Pain trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06812832, a Phase 4 study of Postoperative Pain and Bariatric Surgery, is actively recruiting participants, sponsored by Madigan Army Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 260 participants
- Enrollment target
- 1
- Study location
Study Summary
By conducting this study, we hope to assess if simethicone (also known as Gas Relief or GasX) has an effect on improving gas pain and bloating specifically in patients undergoing foregut procedures to include bariatric procedures (sleeve gastrectomy, Roux-en-Y gastric bypass), hiatal hernia, and gastric surgery. The purpose of this research is to gather information on the safety and effectiveness of simethicone. Simethicone (more commonly known as Gas Relief or Gas-X) relieves pressure, bloating, and fullness commonly referred to as gas. It is FDA approved. The use of this medication in this research study is consistent with labeling indications.
Primary Outcome
Postoperative pain score - based on patient completion of the APS Patient Outcome Questionnaire (APS-POQ-R). Scores are (1) pain severity and relief; (2) impact of pain on activity, sleep, and negative emotions; (3) side effects of treatment; (4) helpfulness of information about pain treatment; (5) ability to participate in pain treatment decisions; and (6) use of nonpharmacological strategies. 0 is no pain and 10 is severe/worst pain possible. Low scores are better outcomes.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Simethicone 80 MG
Study Locations (1)
Washington
- Madigan Army Medical Center - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2025-04-08 |
| Est. Completion | 2029-03 |
| Phase | Phase 4 |
What NCT06812832 shows while recruiting
NCT06812832 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, above the 230-participant average among 120 other Postoperative Pain trials with a reported enrollment target (13% higher).
The record links to 3 conditions, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06812832 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06812832 about?
NCT06812832 is a clinical study titled "Simethicone as Part of ERAS in Bariatric Surgery Patients". By conducting this study, we hope to assess if simethicone (also known as Gas Relief or GasX) has an effect on improving gas pain and bloating specifically in patients undergoing foregut procedures to include bariatric procedures (sleeve gastrectomy, Roux-en-Y gastric bypass), hiatal hernia, and gas...
What is the current status of trial NCT06812832?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 260 participants. The study started on 2025-04-08. Estimated completion is 2029-03.
What conditions does trial NCT06812832 study?
This clinical trial studies the following conditions: Postoperative Pain, Bariatric Surgery, Simethicone.
What interventions are being tested in trial NCT06812832?
The interventions under investigation include: Placebo (DRUG), Simethicone 80 MG (DRUG).
Who is sponsoring clinical trial NCT06812832?
This trial is sponsored by Madigan Army Medical Center, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06812832 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06812832's enrollment target sits among peer trials
260 24th of 120 higher than 97 of 120 other Postoperative Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse
RECRUITING · Phase 4
-
QL Block in Laparoscopic Myomectomy
RECRUITING · Phase 4
-
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
RECRUITING · Phase 4
-
A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi
RECRUITING · Phase 4
-
Preoperative Acetazolamide
RECRUITING · Phase 4
-
Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI